,title,source,link,date
79,"Global Angina Pectoris Drugs Market Size, Share, Forecast 2021 - 2030 | Top key players : Abbott Laboratories,",openPR,news.google.com/articles/CBMiYGh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjIwMDAyL2dsb2JhbC1hbmdpbmEtcGVjdG9yaXMtZHJ1Z3MtbWFya2V0LXNpemUtc2hhcmUtZm9yZWNhc3QtMjAyMdIBX2h0dHBzOi8vd3d3Lm9wZW5wci5jb20vYW1wLzMyMjAwMDIvZ2xvYmFsLWFuZ2luYS1wZWN0b3Jpcy1kcnVncy1tYXJrZXQtc2l6ZS1zaGFyZS1mb3JlY2FzdC0yMDIx?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-22
10,"Mitral Valve Disease Market Segmentation Analysis, Share, Trends, Size, Key Players, and Forecast 2023 to",Benzinga,news.google.com/articles/CBMimQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vcHJlc3NyZWxlYXNlcy8yMy8wOS8zNDgxNDI5OS9taXRyYWwtdmFsdmUtZGlzZWFzZS1tYXJrZXQtc2VnbWVudGF0aW9uLWFuYWx5c2lzLXNoYXJlLXRyZW5kcy1zaXplLWtleS1wbGF5ZXJzLWFuZC1mb3JlY2FzdC0yMDIzLXTSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzQ4MTQyOTk?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-22
31,"Ankylosing Spondylitis Global Market Worth $7.29 Billion By 2027 | Key Players: Pfizer Inc., AbbVie Inc., Nova",openPR,news.google.com/articles/CBMiW2h0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjE4NjM0L2Fua3lsb3Npbmctc3BvbmR5bGl0aXMtZ2xvYmFsLW1hcmtldC13b3J0aC03LTI5LWJpbGxpb27SAVpodHRwczovL3d3dy5vcGVucHIuY29tL2FtcC8zMjE4NjM0L2Fua3lsb3Npbmctc3BvbmR5bGl0aXMtZ2xvYmFsLW1hcmtldC13b3J0aC03LTI5LWJpbGxpb24?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-22
23,"Malaria Treatment Market SWOT Analysis, Industry Revenue, Growth Overview, Industry Share And Forecast To 2032",openPR,news.google.com/articles/CBMiW2h0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjE4MDM5L21hbGFyaWEtdHJlYXRtZW50LW1hcmtldC1zd290LWFuYWx5c2lzLWluZHVzdHJ5LXJldmVudWXSAVpodHRwczovL3d3dy5vcGVucHIuY29tL2FtcC8zMjE4MDM5L21hbGFyaWEtdHJlYXRtZW50LW1hcmtldC1zd290LWFuYWx5c2lzLWluZHVzdHJ5LXJldmVudWU?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-22
1,"Top 10 stocks to watch on September 21, 2023: Zydus Lifesciences, Cochin Shipyard, Olectra Greentech, Patanjali Foods, SJVN & others",Business Today,news.google.com/articles/CBMivgFodHRwczovL3d3dy5idXNpbmVzc3RvZGF5LmluL3Zpc3VhbHN0b3JpZXMvc3RvY2svdG9wLTEwLXN0b2Nrcy10by13YXRjaC1vbi1zZXB0ZW1iZXItMjEtMjAyMy16eWR1cy1saWZlc2NpZW5jZXMtY29jaGluLXNoaXB5YXJkLW9sZWN0cmEtZ3JlZW50ZWNoLXBhdGFuamFsaS1mb29kcy1zanZuLW90aGVycy02NDQwMC0yMS0wOS0yMDIz0gG-AWh0dHBzOi8vd3d3LmJ1c2luZXNzdG9kYXkuaW4vdmlzdWFsc3Rvcmllcy9zdG9jay90b3AtMTAtc3RvY2tzLXRvLXdhdGNoLW9uLXNlcHRlbWJlci0yMS0yMDIzLXp5ZHVzLWxpZmVzY2llbmNlcy1jb2NoaW4tc2hpcHlhcmQtb2xlY3RyYS1ncmVlbnRlY2gtcGF0YW5qYWxpLWZvb2RzLXNqdm4tb3RoZXJzLTY0NDAwLTIxLTA5LTIwMjM?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-21
2,"Stocks that will see action today: September 21, 2023",BusinessLine,news.google.com/articles/CBMidGh0dHBzOi8vd3d3LnRoZWhpbmR1YnVzaW5lc3NsaW5lLmNvbS9tYXJrZXRzL3N0b2Nrcy10aGF0LXdpbGwtc2VlLWFjdGlvbi10b2RheS1zZXB0ZW1iZXItMjEtMjAyMy9hcnRpY2xlNjczMjkwMTYuZWNl0gF5aHR0cHM6Ly93d3cudGhlaGluZHVidXNpbmVzc2xpbmUuY29tL21hcmtldHMvc3RvY2tzLXRoYXQtd2lsbC1zZWUtYWN0aW9uLXRvZGF5LXNlcHRlbWJlci0yMS0yMDIzL2FydGljbGU2NzMyOTAxNi5lY2UvYW1wLw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-21
73,"2023 Concussion Market - Exploration Trends, Analysis, Growth Prospects And Forecast 2032",openPR,news.google.com/articles/CBMiXWh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjE2MDIwLzIwMjMtY29uY3Vzc2lvbi1tYXJrZXQtZXhwbG9yYXRpb24tdHJlbmRzLWFuYWx5c2lzLWdyb3d0aNIBXGh0dHBzOi8vd3d3Lm9wZW5wci5jb20vYW1wLzMyMTYwMjAvMjAyMy1jb25jdXNzaW9uLW1hcmtldC1leHBsb3JhdGlvbi10cmVuZHMtYW5hbHlzaXMtZ3Jvd3Ro?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-21
4,Zydus gets EIR for formulations facility in A’bad,IndiaTimes,news.google.com/articles/CBMidGh0dHBzOi8vbS50aW1lc29maW5kaWEuY29tL2NpdHkvYWhtZWRhYmFkL3p5ZHVzLWdldHMtZWlyLWZvci1mb3JtdWxhdGlvbnMtZmFjaWxpdHktaW4tYWJhZC9hcnRpY2xlc2hvdy8xMDM4MjQ0OTIuY21z0gF4aHR0cHM6Ly9tLnRpbWVzb2ZpbmRpYS5jb20vY2l0eS9haG1lZGFiYWQvenlkdXMtZ2V0cy1laXItZm9yLWZvcm11bGF0aW9ucy1mYWNpbGl0eS1pbi1hYmFkL2FtcF9hcnRpY2xlc2hvdy8xMDM4MjQ0OTIuY21z?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-21
47,Breast Cancer Drugs Market Exploring Share and Scope to 2032 | Growing at a CAGR of 8.4%.,EIN News,news.google.com/articles/CBMif2h0dHBzOi8vd3d3LmVpbm5ld3MuY29tL3ByX25ld3MvNjU2ODk3MzMwL2JyZWFzdC1jYW5jZXItZHJ1Z3MtbWFya2V0LWV4cGxvcmluZy1zaGFyZS1hbmQtc2NvcGUtdG8tMjAzMi1ncm93aW5nLWF0LWEtY2Fnci1vZi04LTTSAYMBaHR0cHM6Ly93d3cuZWlubmV3cy5jb20vYW1wL3ByX25ld3MvNjU2ODk3MzMwL2JyZWFzdC1jYW5jZXItZHJ1Z3MtbWFya2V0LWV4cGxvcmluZy1zaGFyZS1hbmQtc2NvcGUtdG8tMjAzMi1ncm93aW5nLWF0LWEtY2Fnci1vZi04LTQ?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-21
9,Jefferies sees 2% downside potential for Zydus; puts ‘Hold’ rating with target price of Rs 630,The Financial Express,news.google.com/articles/CBMiiwFodHRwczovL3d3dy5maW5hbmNpYWxleHByZXNzLmNvbS9tYXJrZXQvamVmZmVyaWVzLXNlZXMtMi1kb3duc2lkZS1wb3RlbnRpYWwtZm9yLXp5ZHVzLXB1dHMtaG9sZC1yYXRpbmctd2l0aC10YXJnZXQtcHJpY2Utb2YtcnMtNjMwLTMyNTAzODkv0gGQAWh0dHBzOi8vd3d3LmZpbmFuY2lhbGV4cHJlc3MuY29tL21hcmtldC9qZWZmZXJpZXMtc2Vlcy0yLWRvd25zaWRlLXBvdGVudGlhbC1mb3ItenlkdXMtcHV0cy1ob2xkLXJhdGluZy13aXRoLXRhcmdldC1wcmljZS1vZi1ycy02MzAtMzI1MDM4OS9saXRlLw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-21
